After meeting with management at the ICR conference, Piper Jaffray analyst Michael Lavery remains confident in Tilray's long-term strategy. Global regulatory momentum favoring legalization of medical and recreational cannabis products is continuing, and Tilray looks well positioned from a brand perspective with its latest partnership with Authentic Brands Group, which includes many readily recognizable brands, Lavery tells investors in a research note. The analyst expects strong industry growth in the long-term and we believes Tilray is well positioned to be one of several likely winners. He keeps an Overweight rating on the shares.

Widmer Brothers Brewing is launching a new Hefe Variety 12 Pack, showcasing a wide range of delicious wheat beer style brews. The new Hefe Variety Pack includes the brewery's flagship Hefe along with Imperial Hefe, Widberry Hefe, and Apricot Hefe-expanding the Hefe brand family for the first time since the launch of Imperial Hefe last year.

Get caught up quickly on the top news and calls moving stocks with these five Top Five lists.  1... To see the rest of the story go to thefly.com. See Story Here

Alliance Global Partners notes that the Associated Press reported, citing five sources familiar with the matter, that the DEA plans to propose to reschedule cannabis to Schedule III from Schedule I, acknowledging its medical use and lower abuse potential. The firm would view the proposed rescheduling of cannabis as "the most notable cannabis reform in decades" and looks for a formal proposed rule from the DEA in the Federal Register in the near term. The biggest known impact of rescheduling to Schedule III is the removal of the onerous 280E tax, which would provide direct cash benefits to companies that had essentially been paying taxes on gross profits, says the firm, which adds that it views rescheduling as "the first notable domino in terms of cannabis federal reform - with future actions including a Garland Memo & potential SAFER banking." Publicly traded companies in the cannabis space include Aurora Cannabis (ACB), CV Sciences (CVSI), Canopy Growth (CGC), Cronos Group (CRON), Goodness Growth (GDNSF), Green Thumb Industries (GTBIF), IGC Pharma (IGC), Tilray (TLRY), Trees Corporation (CANN) and Trulieve Cannabis (TCNNF).